Facebook
Instagram
Twitter
Vimeo
Youtube
Home
NASDAQ
NYSE
OTCMKTS
Search
Thursday, December 19, 2024
Disclaimer
Privacy
Home
NASDAQ
NYSE
OTCMKTS
Search
Home
Business
Business
Business
NLSP Stock: NLS Pharmaceutics A Beacon of Hope in CNS Disorder Treatment
editor
-
July 29, 2024
Business
ADIL Stock A Beacon of Hope: A Deep Dive into Adial Pharmaceuticals
Business
Silo Pharma (Nasdaq: SILO) Scores Big with Alzheimer’s Therapy
Business
Silo Pharma (Nasdaq: SILO) Soars on Alzheimer’s Drug License
Business
Scinai Immunotherapeutics (Nasdaq: SCNI) Scores with Positive Data (Video)
Business
American Rebel Holdings (NASDAQ: AREB): A Strong Brand
editor
-
June 21, 2024
0
Business
QLogic Corporation (NASDAQ: QLI) Powers Up Growth Potential
editor
-
June 21, 2024
0
Business
Mustang Bio (NASDAQ: MBIO) Muscles Up After Positive Trial Results
editor
-
June 20, 2024
0
Business
Sonneveld Holdings (NASDAQ: SONN): A Sustainable Shrimp Solution for a Growing Market
editor
-
June 20, 2024
0
Business
Allego N.V. Powers Up (NYSE: ALLG) Electrifying Growth
editor
-
June 17, 2024
0
Business
Direxion Daily FTSE Europe Bull 3X Shares (EURL)
editor
-
June 16, 2024
0
Business
Gain Therapeutics (NASDAQ: GANX) Gains Traction
editor
-
June 15, 2024
0
Business
Rezolute Rallies (NASDAQ: RZLT) Strong Financials
editor
-
June 15, 2024
0
Business
American Resources Corporation (NASDAQ: AREC) A Next-Gen Leader in Materials for a Sustainable Future
editor
-
June 14, 2024
0
Business
Kaival Brands Innovations Group (NASDAQ: KAVL) A Hidden Gem in the Consumer Discretionary Sector
editor
-
June 14, 2024
0
Business
Urogen Pharma: Unveiling Potential in Urologic Conditions (NASDAQ: URGN)
editor
-
June 13, 2024
0
Business
Longeveron Soars on Breakthrough Potential in Gene Therapy (NASDAQ: LGVN)
editor
-
June 13, 2024
0
1
2
3
4
Page 3 of 4
- Advertisment -
Most Read
NLSP Stock: NLS Pharmaceutics A Beacon of Hope in CNS Disorder Treatment
July 29, 2024
ADIL Stock A Beacon of Hope: A Deep Dive into Adial Pharmaceuticals
July 23, 2024
Silo Pharma (Nasdaq: SILO) Scores Big with Alzheimer’s Therapy
July 18, 2024
Silo Pharma (Nasdaq: SILO) Soars on Alzheimer’s Drug License
July 16, 2024
